Congressman Raja Krishnamoorthi is right in his Sun-Times op-ed, “Congress can do more to reduce prescription drug costs,” which acknowledged that, as he wrote, “The Inflation Reduction Act is a huge step in the right direction.”
However, when Krishnamoorthi suggested additional legislation needed to lower drug prices, he neglected to include the Affordable and Safe Prescription Drug Importation Act, a bill on which he was an original sponsor as recently as 2019. Expanded access to personal importation is the only solution that can have immediate, broad and long-term savings on prescription drug prices for Americans.
